Literature DB >> 29733072

The importance of intra-hospital pharmacovigilance in the detection of medication errors

Francisco Villegas1, David Figueroa-Montero2, Varenka Barbero-Becerra2, Eva Juárez-Hernández2, Misael Uribe2, Norberto Chávez-Tapia2, Octavio González-Chon3.   

Abstract

Introduction: Hospitalized patients are susceptible to medication errors, which represent between the fourth and the sixth cause of death. The department of intra-hospital pharmacovigilance intervenes in the entire process of medication with the purpose to prevent, repair and assess damages. Objective: To analyze medication errors reported by Mexican Fundación Clínica Médica Sur pharmacovigilance system and their impact on patients. Method: Prospective study carried out from 2012 to 2015, where medication prescriptions given to patients were recorded. Owing to heterogeneity, data were described as absolute numbers in a logarithmic scale.
Results: 292 932 prescriptions of 56 368 patients were analyzed, and 8.9% of medication errors were identified. The treating physician was responsible of 83.32% of medication errors, residents of 6.71% and interns of 0.09%. No error caused permanent damage or death.
Conclusion: This is the pharmacovigilance study with the largest sample size reported. Copyright:
© 2018 SecretarÍa de Salud.

Entities:  

Keywords:  Drug monitoring; Drug safety; Error en la medicación Seguridad de fármacos; Farmacovigilancia; Medication error; Monitoreo de fármacos; Pharmacovigilance

Mesh:

Year:  2018        PMID: 29733072     DOI: 10.24875/GMM.18002549

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  1 in total

1.  A study of medication errors during the prescription stage in the pediatric critical care services of a secondary-tertiary level public hospital.

Authors:  Lorena Michele Brennan-Bourdon; Alan O Vázquez-Alvarez; Jahaira Gallegos-Llamas; Manuel Koninckx-Cañada; José Luis Marco-Garbayo; Selene G Huerta-Olvera
Journal:  BMC Pediatr       Date:  2020-12-05       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.